Reema Choudhry, MBBS

Reema Choudhry practices at Community Medical Center in Toms River, New Jersey, part of RWJBarnabas Health.

Reema Choudhry's NPI, 1457728289, was assigned on August 27, 2015. Reema Choudhry holds New Jersey license 25MA12036500.

Reema Choudhry's primary practice is Community Medical Center, at 99 Rt 37 West, Toms River, NJ 08755 in Ocean County. The practice phone is (732) 557-8000.

Reema Choudhry's primary practice is Community Medical Center in Toms River, New Jersey, part of RWJBarnabas Health. The medical group on file is RWJBarnabas Health Medical Group. Dmand AI also links Reema Choudhry to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Reema Choudhry practices, 2 sites in all. Vendor and product names are available with a free account.

Neurology is Reema Choudhry's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dmand AI has Reema Choudhry's licenses on file in 2 states: New Jersey and New York.

CMS data shows 167 Medicare services from Reema Choudhry across 2 procedure codes in 2024, for 92 Medicare patients. Medicare paid $19,048 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 92 Medicare patients who saw Reema Choudhry in 2024. The largest group is 75 to 84, with 39 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 16% are also on Medicaid. Their average risk score is 2.04, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Reema Choudhry's median patient age at 72, with 58% women.

In 2024, Reema Choudhry wrote 32 Medicare Part D claims. 91% of them were for generic drugs. CMS names the drug for 16 of them, across 1 drug with 11 or more claims each, at $75 in total drug cost. In 2023, CMS named 82 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Reema Choudhry for performance year 2024, reported through an alternative payment model (APM). Reema Choudhry accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 1 paper to Reema Choudhry in 2022. Reema Choudhry's most frequent co-authors are Emmanuel Oladele Akano, MD, Ehimen Aneni, MD and Timothy Michael Beutler, MD.

CMS Open Payments shows 2 general payments to Reema Choudhry from 2 drug and device companies from 2018 to 2019. Food and beverage make up the largest share, 100% of the total. Novartis Pharmaceuticals Corporation paid the most, $125.